 Oncolytics Biotech, Inc. NASDAQ:ONCY Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Corporate Participants Jon Patton - Director, Investor Relations and Communications Matthew Coffey - President and Chief Executive Officer Thomas Heineman - Chief Medical Officer Andrew de Guttadauro - Global Head of Business Development, President, Oncolytics Biotech U.S. Inc. Kirk Look - Chief Financial Officer Conference Call Participants John Newman - Canaccord Jason Kolbert - HC Wainwright Operator Good afternoon, and welcome to Oncolytics Biotechs First Quarter 2022 Conference Call. All participants are now in a listen-only mode. 